Laura Pallesen

·Exceeded quota 6 out of 8 quarters

·Q4 2023 finished 1st in region for both case and revenue growth out of 38

·Q2 2023 finished 2nd in region out of 35

·Q4 2022 finished 11th out of 300, 1st in region out of 28

·Periodically host field-based training for newly hired Account Managers

·Demonstrate leadership to the Account Manager team

·Responsible for growing Endovascular procedures and building VTE programs across 5 hospitals

·Provided on-call case support 24 hours a day, 7 days a week

·Successfully grew territory 276% over 24 months

·Developed relationships with Emergency Department physicians to build strong referral patterns to end users

·Negotiate local pricing contracts to maximize utilization

·Identified and cultivated business with new physicians

·Partnered with Engineering, R&D, Marketing to support customers

·Strategically launched 5 new products in 24 months

·Collaborated with Capital Team and hospital C-Level to sell $2 million of capital equipment to Glendale Adventist

·First to launch Robotic Bariatrics in territory, trained #2 highest volume Bariatric surgeon in market that resulted in $54,805 in advanced technology and achieving 127% in advanced tech quota

·Launched Glendale Memorial's Robotic Program. Worked with Business Development, Marketing, and Administration to ensure success and become Robotic Center of Excellence in 12 months

·Finishing 2021 with 50% YoY total procedure growth and 80% YoY General surgery growth

·Trained 10 Sustainable Robotic surgeons within tenure, doubling size of territory and robotic procedures performed

·Responsible for procedural growth, advanced technology growth, and capital equipment sales

·Clinically sold and trained #1 GYO in market to become Surgeon Champion and MD of Robotic Program. Established monthly steering committee meetings with administration, resulting in program growing 230%% and reaching system capacity

·Launched Kaiser Panorama City's Robotic General Surgery program increasing procedural volume by 30%

·Increased the amount of Robotic General surgery procedures in territory by 130%

·Q3 2018 - 112%, Q1 2019 - 104% and grew business 26%

·Independently lead evaluation and successfully implemented Endomechanical product at Adventist Health Bakersfield generating $75,000 annually in revenue

·Increased Gelpoint business 321% from 2017 to 2018

·Review GPO contracts, Cost Saving Analysis, and Business Reviews with customers

·Sold entire laparoscopic product portfolio and supported clinical procedures pertaining to General, Colorectal, OB/GYN, Bariatric, Orthopedic, and Urology

·Supported West region during large evaluations; Independently lead trocar evaluation and completed implementation at CHI St. Clare Hospital

·Worked closely with OR leadership and Supply Chain to support and promote products

·Responsible for promoting and growing Pneumovax23 and Zostavax sales across San Joaquin County region

·Increased Pneumovax23 sales by 31% and Zostavax by 24%